Cite
HARVARD Citation
Tzogani, K. et al. (n.d.). The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: Summary of the scientific assessment of the Committee for Medicinal Products for Human Use. Journal of dermatological treatment. pp. 371-374. [Online].